178
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Centromeric fragment of chromosome 7 in atypical chronic myeloid leukemia with the SET binding protein 1 gene mutation

, , , , , , , , , , , , & show all
Pages 826-828 | Received 14 May 2014, Accepted 23 Jun 2014, Published online: 04 Aug 2014

References

  • Vardiman JW, Bennett JM, Bain BJ, et al. Atypical chronic myeloid leukaemia, BCR-ABL1 negative. In: Swerdlow SH, Campo E, Lee Harris N, et al., editors. WHO classification of tumors of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2008:80–81.
  • Meggendorfer M, Bacher U, Alpermann T, et al. SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations. Leukemia 2013;27:1852–1860.
  • Piazza R, Valletta S, Winkelmann N, et al. Recurrent SETBP1 mutations in atypical chronic myeloid leukemia. Nat Genet 2013; 45:18–24.
  • Maxson JE, Gotlib J, Pollyea DA, et al. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. N Engl J Med 2013;368:1781–1790.
  • Pardanani A, Lasho TL, Laborde RR, et al. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. Leukemia 2013;27:1870–1873.
  • Shaffer LG, Slovak ML, Campbell LJ, editors. ISCN 2009: an international system for human cytogenetic nomenclature. Basel: Karger; 2009.
  • Lichter P, Tang Chang CJ, Call K, et al. High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science 1990;247:64–69.
  • Breccia M, Biondo F, Latagliata R, et al. Identification of risk factors in atypical chronic myeloid leukemia. Haematologica 2006; 91:1566–1568.
  • Hernandez JM, del Cañizo MC, Cuneo A, et al. Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia. Ann Oncol 2000;11:441–444.
  • Gotlib J, Maxson JE, George TI, et al. The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment. Blood 2013;122:1707–1711.
  • Singbrant S, Wall M, Moody J, et al. The SKI proto-oncogene enhances the in vivo repopulation of hematopoietic stem cells and causes myeloproliferative disease. Haematologica 2014;99:647–655.
  • Lizcova L, Zemanova Z, Malinova E, et al. A novel recurrent chromosomal aberration involving chromosome 7 in childhood myelodysplastic syndrome. Cancer Genet Cytogenet 2010;201:52–56.
  • Beeharry N, Rattner JB, Caviston JP, et al. Centromere fragmentation is a common mitotic defect of S and G2 checkpoint override. Cell Cycle 2013;12:1588–1597.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.